Search

Bionovo, Inc. (BNVI)

0.00
N/A (N/A)
RangeN/A - N/A
52 weekN/A - N/A
Open-
Vol/Avg.0
Mkt cap-
P/E-
EPS-
Book/share-
Short ratio-
PEG-
EPS est.-

BNVI additional information

Loading ...
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
 

BNVI Profile

Exchange
NASDAQ
Sector
Executives
Dr. Isaac Cohen L.Ac. M.D.
49
Co-Founder Chairman Chief Exec. Officer Chief Scientific Officer Member of Nominations Committee and Member of Governance Committee

Dr. Mary Tagliaferri M.D. Ac.
46
Co Founder Pres Chief Regulatory Officer Chief Medical Officer Medical Director Treasurer Sec. Director Member of Medical Advisory Board and Member of Nominations Committee

Mr. Robert E. Farrell J.D.
Interim Chief Financial Officer
Director Member of Audit Committee Member of Nominations Committee and Member of Compensation Committee

Dr. Uwe Christians M.D. .D.

Member of Scientific Advisory Board and Head of Laboratory at Fitzsimmons Biotechnology Park

Dr. Klaus D. Kohl Ph.D.
Chief Technical Officer and Sr. VP

Index Membership
N/A
Employee Count
5

Competitors

Ticker Last trade Change/%change P/E ratio  
PFE 26.88 -0.08 / -0.30% 13.92
AZN 47.43 -0.04 / -0.08% 9.53
BMY 37.03 +0.54 / +1.48% 31.43

BNVI earnings

Date
Actual
Expected
Prev Yr Qtr
11/10/2011
-0.07
-0.16
-0.21
8/3/2011
-0.14
-0.13
5/11/2011
-0.11
-0.10
-0.04

Trading Offers